Q3 2025

Filed Apr 14, 2025 · 10-Q · 45 days after period end · 0001641172-25-004571

Q3 2025 · 10-Q

Revenue

$1.12M

+10.0% vs Q3 2024

Net Income

-$1.16M

N/M vs Q3 2024

EPS Diluted

-$0.48

N/M vs Q3 2024

Gross Profit$19,000N/M

Operating Income

Same quarter

Metric	Q3 2025	Q3 2024	Q3 2023	Q3 2022
Revenue	$1.12M	$1.02M	$1.11M	$7.66M
Net Income	-$1.16M	-$1.92M	-$1.65M	-$104.17K
EPS Diluted	-$0.48	-$0.11	-$0.12	-$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Biomerica Inc · CIK 73290 · Engraved from SEC EDGAR